JPMorgan lowered the firm’s price target on Imax (IMAX) to $26 from $27 and keeps a Neutral rating on the shares. The firm updated its model for Imax, citing risks related to China and exhibitor capex amid the trade war.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- China to ‘moderately reduce’ imported U.S. films over tariffs
- IMAX’s Resilience and Growth Potential in China: Buy Rating Affirmed Amid Market Uncertainties
- Toho Cinemas, Imax expand partnership with Japan
- Imax unveils expansion of its IMAX Enhanced program
- IMAX to expand, upgrade across 80 AMC Theatres in U.S.